Sélection de la langue

Search

Sommaire du brevet 1189079 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Brevet: (11) CA 1189079
(21) Numéro de la demande: 1189079
(54) Titre français: AMINES PERFLUOROTRICYCLIQUES
(54) Titre anglais: PERFLUOROTRICYCLIC AMINE COMPOUNDS
Statut: Durée expirée - après l'octroi
Données bibliographiques
(51) Classification internationale des brevets (CIB):
  • C07D 209/56 (2006.01)
  • C07D 221/22 (2006.01)
(72) Inventeurs :
  • YOKOYAMA, KAZUMASA (Japon)
  • FUKAYA, CHIKARA (Japon)
  • TSUDA, YOSHIO (Japon)
  • ONO, TAIZO (Japon)
  • ARAKAWA, YOSHIO (Japon)
  • INOUE, YOSHIHISA (Japon)
  • NAITO, YOUICHIRO (Japon)
  • SUYAMA, TADAKAZU (Japon)
(73) Titulaires :
  • YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD.
(71) Demandeurs :
  • YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD. (Japon)
(74) Agent: SMART & BIGGAR LP
(74) Co-agent:
(45) Délivré: 1985-06-18
(22) Date de dépôt: 1983-03-30
Licence disponible: Oui
Cédé au domaine public: S.O.
(25) Langue des documents déposés: Anglais

Traité de coopération en matière de brevets (PCT): Non

(30) Données de priorité de la demande: S.O.

Abrégés

Abrégé anglais


ABSTRACT OF THE DISCLOSURE
A perfluorotricyclic amine compound which
is usable as an oxygen carrier in an artificial
blood, represented by the general formula
< IMG >
wherein R denotes a perfluoroalkyl group having 1 - 4
carbon atoms; the ring A denotes a five- or six-
membered ring, the ring B denotes a five-, six-
or seven-membered ring, the ring C denotes a five-
or six-membered ring any one of the rings A, B and
C optionary being substituted by one or more lower
perfluoroalkyl group in addition to the above-
mentioned substituent R; and further f, g, h, i, j
and k denote integers appropriately selected to
construct the above-mentioned size of rings A, B,
and C; is prepared by reacting the corresponding
perhydrotricyclic amine with fluorine.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A perfluorotricyclic amine compound represented by
the general formula
(I)
< IMG >
wherein R denotes a perfluoroalkyl group having 1 to 4 carbon
atoms; the ring A denotes a five- or six-membered ring, the
ring B denotes a five-, six- or seven-membered ring, the ring
C denotes a five or six-membered ring any one of the rings A,
B and C optionally being substituted by one or more lower per-
flouroalkyl group in addition to the above-mentioned substi-
tuent R; and further f, g, h, i, j and k denote integers ap-
propriately selected to construct the above-mentioned size of
rings A, B and C.
2. A process for producing a perfluorotricyclic amine
compound represented by the formula,
26

< IMG > (I)
wherein R denotes a perfluoroalkyl group having 1 -
4 carbon atoms; the ring A denotes a five- or six-
membered ring, the ring B denotes a five-, six-
or seven-membered ring, the ring C denotes a five-
or six-membered ring any one of the rings A, B and
C optionary being substituted by one or more lower
perfluoroalkyl group in addition to the above-
mentioned substituent R; and further f, g, h, i, j
and k denote integers appropriately selected to
construct the above-mentioned size of rings A, B
and C, which comprises reacting a perhydro-compound
of the formula,
(II)
< IMG >
27

wherein R' is an alkyl group having 1 - 4 carbon atoms, f, g,
h, i, j and the rings A, B and C are same as above, with
fluorine.
3. A compound according to claim 1, wherein f is 1, 2,
3 or 4; g is 0, 1 or 2; h is 0 or 1 and i, j and k are each 0,
1, 2 or 3.
4. A compound according to claim 3, wherein R is per-
fluoromethyl or perfluoroethyl.
5. A compound according to claim 3, wherein none of the
rings A, B and C is substituted by a perfluoroalkyl group or
one of the rings A, B and C is substituted by a perfluoromethyl
group in addition to the perfluoroalkyl group R.
6. A compound according to claim 2, 3 or 5, wherein the
total number of the carbon atoms in the compound is 8 to 12.
7. A compound according to claim 1, which has the fol-
lowing formula:
< IMG >
28

wherein rings A, B and C are as defined in claim 1; f + g + h
+ i + j + k + ? + m + n = 5 or 6; f is 1, 2 3, or 4; g is 0,
1 or 2; h, ?, m and n are each 0 or 1; and i, j and k are each
0, 1, 2 or 3.
8. Perfluoro-4-methyl-4-azatricyclo[5,2,1,0,2,6]decane.
9. A process according to claim 2, wherein the reaction
is performed by mixing anhydrous hydrogen fluoride and the
starting perhydro-compound in an electrolytic cell and subjec-
ting the resulting solution to electrolysis.
10. A process according to claim 2, wherein a suitable
starting perhydro-compound is chosen so as to produce a per-
fluoro-compound as defined in claim 7.
11. A process according to claim 2 or 9, wherein the
total number of carbon atoms in the compounds of formulae (I)
and (II) is 8 to 12.
12. A process for producing perfluoro-4-methyl-4-azatri-
cyclo[5,2,1,0,2,6]decane, which process comprises fluorinating
4-methyl-4-azatricyclo[5,2,1,0,2,6]decane.
13. A process according to claim 12, wherein the fluori-
nation is performed by first mixing anhydrous hydrogen fluoride
and the starting material in an electric cell and then subjec-
ting the resulting solution to electrolysis.
29

14. A process according to claim 9, which further com-
prises (i) isolating the product perfluoro-compound, (ii) mixing
the perfluoro-compound with (a) a physiologically acceptable
aqueous medium and (b) a nonionic surfactant or a phospholipid
as an emulsifer, the amounts of the perfluoro-compound and the
emulsifier being 5 to 50% (W.V) and 1 to 5% (W/V), respectively,
and finally (iii) homogenizing the mixture thereby forming an
emulsion until the particle diameter becomes 0.05 to 0.3 µm.

Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


1 This invention relates to a novel perfluoro-
tricyclic amine compound useful as an oxygen carrier
in ';an artificial blood or in an infusion fluid.
More particularly, it relates to perfluoro-
tricyclic amine compounds represented by the general
formula
--~ ~ (CF2) j
~ CF CF
(CF2)f A (CF2)g B (CF2)i C N-R (I)
~ ~ (CF ) ~ ~ (CF ) ~
wherein R denotes a perfluoroalkyl group having
from 1 to 4 carbon atoms, the xing A denotes a
five- or six-membered ring, the ring B denotes a
five-, six- or seven-membexed ring, the ring C
denotes a five- or six-membered ring, and f, g, h, i,
j and k denote integers appxopriately selected to
construct the above-mentioned size of rinys A, B and
C. In that case, the compound may be substituted
by one or more lower perfluoroalkyl group(s) in
addition to -the above-mentioned substituent R.
Regarding the general formula (I), as
, -- 1 --

~i~
1 mentioned above, f, g, h, i, j and k are integers
appropriately selected to constru~t a five- or
six-membered ring A, a five-, six- or seven-membered
ring B and a five- or six-membered ring C, respec-
tively. Individually, each of the int:egers isappropriately selected, for example, from:
1, 2, 3 and 4 for f; O, 1 and 2 for g; O and 1 for h;
and 0, 1, 2 and 3 for each of i, j and k.
In the general formula (I), the lower
perfluoroalkyl group denoted by R may be either of
straight chain or of branched chain. Examples
thereof include those having l to 4, preferably l
to 2, carbon atoms, such as perfluoromethyl ~roup,
perfluoroethyl yroup, perfluoro-n-propyl group,
perfluoroisopropyl group, perfluoro-n-butyl group,
perfluoroisobutyl group, perfluoro-sec-butyl group
and perfluoro-tert-butyl group.
Rings A, B and C, especially rings A and
C may be substituted at any position thereof by one
or more than one, preferably one or two, lower
perfluoroalkyl group(s) in addition to the above-
mentioned substituent denoted by R. Examples of the
lower perfluoroalkyl groups suitable as such
substituents are similar to those which are described
above referring to R. Perfluoromethyl group is
especially preferred. In case where two or more of
su~stituents are present, they may be different
from each other.

The total number of carbon atoms present in the com-
pound of formula (I) is generally from 8 to 12, preferably 10
or 11.
As an embodimen-t of -the compound of formula (I),
mention may be made of a compound represen-ted by the general
formula
( 3 m ( 3)n
\ (I')
/--1 ,~ (CF'2 ) j
~ CF CF
(CF2)f A (CF2)g B ~I 2)i C J -(CF2)Q(CF3)
CF \ / CF
\ (CF2)h ~ (CF2)k
wherein rings A, B and C are as defined above; f -~ g -~ h + i -
~j + k + Q + m + n = 5 or 6, f denotes, 1, 2, 3 or 4; g de-
notes 0, 1 or 2; h, Q, m and n clenote each O or l; and i, jand k denote each 0, 1, 2 or 3.
The compound of formula (I) can be prepared by
fluorinating a perhydro-compound (II) corresponding to the
compound of formula (I).
- 3 -

~ CH ~ / (CH2)j (II)
(CH2)f A (CH2)g ~ (t H2)i C N-R'
~ CH CH
wherein R' is an alkyl group having 1 - 4 carbon stoms, f, g,
h, i, j and the rings A, B and C are the same as above, with
fluorine.
The methods of :Eluorination include, :Eor example, a
direct fluorination, a fluorination by use of cobalt trifluoride,
and an electro chemical Eluorination.
The preparation of the compound of formula (I)
- 3a -

1 of this invention is preferably performed by the
electrochemical fluorination method. This is
performed, for example, by mixing anhydrous hydrogen
fluoride and a perhydro-compound used as the starting
compound in an electrolytic cell and subjecting the
resulting solution to electrolysis. The voltage,
the current density at the anode, and the temperature
of electrolytic solution are normally 3-9 V, 0.2 -
3.0 A/dm2 and 4-10C, respectively.
The compound o formula (I) thus formed
was drained from the bottom of the cell, being
insoluble in anhydrous hydrogen fluoride.
The isolation and purification of the
compound from the drained product are carried out,
for example, by adding a mixture of equal volumes
of an aqueous alkaline solution and an amine compound
to the drained product, refluxing, then separating
the lowermost layer containing the desired compound
of formula ~I) (the partially fluorinated compounds
decomposed in this process), washing the former
layer with an aqueous acetone solution containing a
suitable amount of potassium iodide to remove
perfluoroalkyl nitrogen fluorides, and by subsequent
fractional distillation to obtain the fraction of
the desired compound of formula (I).
Since the compound of the formula (I) of
this invention can dissolve a large amount of oxygen,
chemically and biologically inert, and can be excreted
-- 4

1 rapidly from the body, it can form, for example,
an aqueous emulsion containing 5 to 50, preferably
10-40, ~(W/V) of the compound of formula II) to be
used as an oxygen carrier in an artificial blood
or in an infusion liquid for men and other mam~als
such as dogs, cats, cattle, mice, rats and guinea
pigs.
The symbol "%~W/V)" referrecL to herein
mean the amount of the material by weight (gram) based
on 100 ml of the resulting emulsion.
In the preparation of the emulsion mentioned
above, there used, as an emulsifier, a nonionic
surfactant or phospholipids in an added amount of
1 to 5~ (W/V).
As the medium for the emulsion, a
physiologically acceptable aqueous solution is
employed. If necessary, there may be added thereto
such materials as inorganic salts to provide the
desired isotonicity, and such plasma expanders
as HES or dextran to regulate the osmotic pressure
of the emulsion.
The emulsion can be prepared by mixing
the above-mentioned ingredients and homogenizing
the mixture by means of, for example, a high-
pressure iet type homogenizer until the particlediameters become 0.05 to 0.3 ~m, preferably less
than 0.2 ~m.
The perhydro-compounds (starting compounds)

~89~9
1 corresponding to the compounds of ~ormula (I) are
substantially known already.
Example
The e~uipment employed in the fluorination
was a Monel reaction cell, through which coolant
could be circulated for temperature control. Power
was supplied to the cell pack by a 0 - 50 amp, 0 - 50
V-DC power supply. The cell pack consisted of 13
nickel plates (more than 99.6% purity) separated
with Teflon spacers, and arranged alternately so
that the seven odd numbered plates were cathodes
and the six even numbered plates were anodes.
The spacing between plates was 1.7 - 2.0 mm.
The cell was equipped with a copper condenser,
through which coolant was circulated by a refrigera-
tion unit. The progress of an electrolysis was
monitered by a voltage-current recorder. In the
electrolytic cell, was placed 1.2 liter of hydrogen
fluoride, and trace amounts of impurities present
in the system (moisture or sulfuric acid) were
removed by preliminary electrolysis. Then, 0.675 mol
(102 g) of 4-methyl-4-azatricyclo[5,2,1,02'6]decane
was introduced into the cell, and the electrolysis
was continued, while introducing nitrogen gas from
the bottom of the cell at a rate of lOQ ml/min.,
under the conditions of anode current density of
O.4 - 2.0 A/dm2, voltage of 5 - 7 V and solution
-- 6

~ ~39~79
1 temperature of 7 - 12C, until the ampere-hours
amounted to 730. Fresh anhydrous hydrogen fluoride
(300 ml) was added every 24 hours during the
electrolysis. No attempt was made to collect
volatile products ormed by a bond breaking reaction.
~fter completion of the electrolysis, fluorocarbons
in the lower layer in the cell was drained through
the bottom of the cell, weighed 260 g (57~ yield).
To the fluorocarbons thus separated, were
added equal volumes of 70% aqueous potassium hydroxide
solution and diisobutylamine, and the resulting
mixture was refluxed for about five days. The
reaction mi~ture was then cooled in an ice bath.
The perfluoro-compounds sedimented in the lowermost
layer were separated in a separatory funneL, washed
successively with water, concentrated sulfuric acid,
saturated aqueous sodium hydrogen carbonate solution
and 9~ aqueous acetone solution containing 3% of
potassium iodide, and finally several times with
water to yield 162.0 g of perfluoro-compounds contain-
ing no protons. This was distilled on a fractional
distillation apparatus equipped with a spinnin~
band column to afford 39.2 g (8.6~ yield) of the
desired product boiling at 143 - 152C. This product
was purified, then analyzed by infrared absorption
spectrometry, 19F-nuclear magnetic resonance spectro-
metory and mass spectrometory, and was confirmed to
be the objective compound, perfluoro-4-methyl 4-

azatricyclo[5,2,1,02'5]decane.
A series of other perfluorotricyclicamine compounds were synthesized and purified in the
same manner as that described above and each product
was conirmed to be the objective compound upon
analysis by infrared absorption spectrometory, 19F-
- nuclear magnetic resonance spect~ometory and mass
spectrometory.
The structural formula and the boiling point
of each of the objective compounds is shown in the
Table. The symbol "F-" in the structural formula
indicates that the compound is perfluorinated. For
example, the formula
indicates in its exact meaning the formula
CF2
,,, ~ F C2
F 1~CF\ ¦ / -CF 2 -CF3
F 2
-- 8 --

~L~I 3907~
O ~ u~ ~ In
-- U~
,,
,, ~
~ ~ CO ~ ~D I
o o ~ U~
~Q,
C~
~ r1~
~ U
Q~
r~l ~_ I
Q
(d
E~
O ~
~ O
I I
` O O
~1
~ u~ ` U
~1
a~ ~ o --~ ,, ,u,
U~
Q rl U N ~ N
O ~ ~-I I U I U
a ~ ~ a) ~r a
N
S-l~d N ~ r~
(l~I It
~et~
~1 I a.l o V o
E
a) ~ ~ ~ I ~ I
U ~ u er ~
_ ...
O ~ ~ ~ ~r
z;

!3~D7~
~D r
C
o
C~
_. I
~4 ~4 ¢~ ~4 ~4
-- . ~
o
I
O
E~ O O -1
,_1 ~ C)
C~ O ~
C~ I
rl O
~1 rl h ~1 0
N ~ N
S ` S ` ~ ` ~ ` I `
a) o o o ~3 o ~J o I o
Q ~ S
o ~ a~
..
u~ ~D r~
.
-- 10 --

~89~7~
_
u
h
U
a
,~
~ I I I I I
El O O O O O
C)
N ~ Ni:~ N ~ N ~ N
r I ~_~i r--r--I r_ ~_~ ~_ ~,~ ~_
C ~S) ,~
o a) o~ o ~ o Q) O
ri r~ ri r~r~ r~ r~ rl r~
Q ` t~ ` a ~ ~ ~
-
o ,~
r~ ~I r~
_

8~7~
~O
O L~
.,.
o
I
.
C~
~1
I
o
E~ O O O ~
U
~, U U ~
U U U rl O
.,, .,, .,, "
N O U 1
N ~ N ~ N ~ ~ ~ rl t~
U I O I U ~ C) ~ ~
I 'IS I ~ --1 rO N :)
~ o ~ o ~ o ~ o ~ o
~ ~ ~ I ~ o ~ a~
,n ~D t~ 00 '

o
c~
- - - - - -
o
c~
-
E~
o o o o o
c~ c~ Q~ C~a~ c~ a~
-1 C) rl C) ~1 U ~1C) ~1 C~
h a~
N ~ N ~ N ~ N ,!:~ N ~:)
~1 0 ~1 ~1 ~1 ~1 ~1 0 ~1 0
o
-

~8~
Ln Ln
r~ r~ r~ ~1 r~
Ln Ln
U~ Ln Ln Ll~ Ln
o
_z~~
'Cl
. . . _ _ _ _ -- -- . . . . . . . . . . . . . ~ _ . . _ ~ _ _-- . ~ m . . _ _
~,
r
E~
o o o o o
,) rl t) rl Or~ t) rl t~
N N ~ N ~S N ::1 N
r~ O r~ O r-~ O r~ O r~ O
I Ln I Ln I ~ I
Ln
- -
Ln ~D ~ a~ ~
-
-- 14 --

~3~79~
.
~D ~D W
n u~
r~ ~I
o
I
o
-
r
E~
O O O O O
.
U ~
~ V ~ U
~ ~a ~ a
N ~:S N ' N I N :::1 N
~ o ~ O ~ O ~ O ~ O
,~ o ,~
x ~
-
o .~ ~ ~ ~r
-- 15 --

l r-l ~I r-l
~ Ln u~ I
r-l~~l r-t r-l r-l
O
t
o
-
Q
¢~ I I I
E~ O O O
r-l r~
U U t)
O I U U U
r l .rt ~rl rl
U r
U 'I~
t ~ ¢~
rl ~ U 1~ N ~ M i:~ N
¢5 rl ~ ¢~ ¢~ ¢1 ¢~ ta
U 5-1 U I U I U I U
N rCt ¢t ~ I ~ I ra I
N ~ ~I r~ r~l ~
I N (~ N 1~ N ~ N ~ N
r~l I r l a~ r-l a) r~l a.) r~l
~ r-l rl r-l ~ rl r-l ~ rl ~¦
a ~ a ~ ~ ~
a~N ~ N I N I N I N
~~ r l ~-- N ~~
.
-- 16 --

7~9
,
o
C~
z Z-. I æ z
-
... ..
o
C~
-
a)
E-l O O O O O
U O C.) C~
h
N ~: N ~ N ~ N 1:: N
S ` ~ ` ,~
I ~) N ~ `1 ~ ~ ~ N
` A ` A ` A ` Cl
N I N I N I t~
O --1 N
et' ~r
- 17 --

7~
.
o
V
, ~
o
-
a)
I
o
E~ ~
~ o o o
,~ o
~1 ~ N ::~ N ~ N ~ n~ ~
O I O
o ~ ~ ~ a~ ~ ~ ~~ ~
` er I Ln I L-) I In I In
-- 18 --

~L~8~3~
o
-
-
o
U
-
,1
R
td I I I I I
E~ O O O O O
V U U U
V U V
0 a~
N C: N ~ N ,C~ N ~ N ~:
U I V I U I U
o a) o ~ o a)~ O
a ~
O ~ ~ ~ ~
Ul Lt~ U~ Ln In
-
-- 19 --

~890~
~9 ~ CO l
,, ~ ,. ..
o
_ _ _
¢, ¢, ¢, ¢, ~
-
o
~,
-
,
I
o
o o o ~
,, ~ ~ C)
U U U
~ ~ ~ C) ,
U U U ,, o
.~ .,, .,, s
s~ ~ ~ U ~
N ~ N C N ~ rl U
C~ I U I U O~ U ~) ~
O ~ O ~ O ~ O ~ O
a ~ a
N I ~ o ~ a
.
u~ ~ r co a~
-- 20 --

79
.. ...
I` Ln
n
Ln Ln Ln Ln Ln
: _ _ O
Z~ ~
.~
Or_
a) o
.
Q,_~
a
E~ ~
I
~D O O
O O O O
~\ ~ '~ ~ '~1 N '~; N '1~
N N ~I N ,1 1 ~ I 1
O ,_ ~ ._
I r~ I Ln
I L~ I ~ ~ ~ ~ ~
.~ a~.~ o .~ .~ ~, o ~ o
r~ r; ~ ; rL ~ ~ ~
a~ ~ L~
o Ln .~ Ln
- -
o .~ ~ ~ ~:r

79
.
o
... .. . . ~,
Z ~V
o
C~
, , ,
o o o
E~ V
o
o ... ... ...
C~ ~i h
U ~ ~ ~ ~
~1 U N N N
o ~ o ~ o ~
N ~ I o ~ o I O
~1 ~ O ~
o ~ o k ~3 ~3
~ o ~ o ~ o
o In o u~
-- 22 --

~D ~ Ln ~ Lf) I
o
~z ~z ~
1:4 h h h h
-
g
C~
-
G)
,1 1 1
R O O
b
.,, ,, ~ I
o
o
0 o a) v ~I
a) 0 a~ ~ 0 c) a~ ~ ~
o 0 o 0 0 a) ~ 1 0
N ~ 0
~ 0 ~ N
E~ O ~j O ~ O ~1 ~1 I~1
Q ~-i Q
O ~ O
, . . .. ... _ . _ . _ _ _
O ~ ~ ~ el
-- 3 --

~9~79
,. Ln ~O In ~
~ D
r~ ~ r~ r~ r~
~D ~D ~ I
Ln n o In n
o
'
I
r~
o
-
,~
I
o
E~ O O O O r~
r~ r~ r~ r~ C)
C~ U U U
U
~ V C) ~ r~
,~ ,~ r l r-l h
al C~ a) N al
N ~: N ~, N ~ N
0 r~
U I U I U I U ~ U
I r~ I r~
n ~, Ln ,1: n
a ~
I ~ I ~ I ~ o
~ r~
Ln ~o 1` oo
-- 24 --

79
Ln U7 .,.
o
C~
-
a~
.
E~
o o o
,. .. ..
c~ a) o a~ u
,, ~ .,, ~ .,,
N ~ N ~:1 N
o ~ ~ _. O
O
~ ` .C
O U~ D o u~
O ~1
00 00 .
-- 25 --

Dessin représentatif

Désolé, le dessin représentatif concernant le document de brevet no 1189079 est introuvable.

États administratifs

2024-08-01 : Dans le cadre de la transition vers les Brevets de nouvelle génération (BNG), la base de données sur les brevets canadiens (BDBC) contient désormais un Historique d'événement plus détaillé, qui reproduit le Journal des événements de notre nouvelle solution interne.

Veuillez noter que les événements débutant par « Inactive : » se réfèrent à des événements qui ne sont plus utilisés dans notre nouvelle solution interne.

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , Historique d'événement , Taxes périodiques et Historique des paiements devraient être consultées.

Historique d'événement

Description Date
Inactive : Périmé (brevet sous l'ancienne loi) date de péremption possible la plus tardive 2003-03-30
Inactive : Périmé (brevet sous l'ancienne loi) date de péremption possible la plus tardive 2003-03-30
Inactive : Renversement de l'état périmé 2002-06-19
Lettre envoyée 1999-05-11
Accordé par délivrance 1985-06-18

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Historique des taxes

Type de taxes Anniversaire Échéance Date payée
Enregistrement d'un document 1999-03-24
Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD.
Titulaires antérieures au dossier
CHIKARA FUKAYA
KAZUMASA YOKOYAMA
TADAKAZU SUYAMA
TAIZO ONO
YOSHIHISA INOUE
YOSHIO ARAKAWA
YOSHIO TSUDA
YOUICHIRO NAITO
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document. Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.


Description du
Document 
Date
(aaaa-mm-jj) 
Nombre de pages   Taille de l'image (Ko) 
Abrégé 1993-06-11 1 17
Page couverture 1993-06-11 1 17
Revendications 1993-06-11 5 101
Dessins 1993-06-11 1 7
Description 1993-06-11 26 454